BRIEF-EMA Says CHMP Recommended Granting A Full Marketing Authorisation To Veklury

Reuters | Updated: 22-07-2022 16:57 IST | Created: 22-07-2022 16:37 IST
BRIEF-EMA Says CHMP Recommended Granting A Full Marketing Authorisation To Veklury
European Medicines Agency

Gilead Sciences Inc:

* EMA SAYS COMMITTEE RECOMMENDED GRANTING A FULL MARKETING AUTHORISATION TO VEKLURY (REMDESIVIR), AN ANTIVIRAL MEDICINE USED TO TREAT COVID-19 Source text for Eikon: Further company coverage:

TRENDING

1
Development Banks Revamp Finance Measures to Show How Private Capital Fuels Growth

Development Banks Revamp Finance Measures to Show How Private Capital Fuels ...

Netherlands
2
EXCLUSIVE-Citing Iran war, US waives rights condition on Egypt military aid

EXCLUSIVE-Citing Iran war, US waives rights condition on Egypt military aid

Global
3
Trump appears at Texas rally with former NBA star Dennis Rodman

Trump appears at Texas rally with former NBA star Dennis Rodman

Global
4
Brazil election's final TV debate scrapped as Lula, Flavio Bolsonaro skip

Brazil election's final TV debate scrapped as Lula, Flavio Bolsonaro skip

Global

PERSPECTIVES AND INSIGHTS

When Family Law Shapes the Economy: Chile’s Divorce Reform Offers Lessons for Policymakers

From Oil Shale to Wind Power: Estonia’s High-Stakes Plan for Cheaper, Secure Electricity

From Debt Pressure to AfCFTA: Africa Searches for a New Formula to Finance Growth and Jobs

Building Resilience Before Crisis Hits: Asia-Pacific Reimagines the Future of Social Protection

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026